Omeros Corp - Company Profile

All the sales intelligence you need on Omeros Corp in one solution.

Save hours of research time with a comprehensive
Sales Intelligence Solution.
Understand how Omeros Corp fits into your total
addressable market and Ideal Customer Profile.
Gain competitive edge with triggers that tell you
when and how to engage with Omeros Corp.

Omeros Corp: Premium Databases

Contact the team or request a demo to find out how our data can drive your business forward

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Headline	Published	Journalists
Showing 3 of 8 results.
Deserunt mollit sunt Lorem laborum do id aliqua dolore	28 Apr 2021	Lorem
Omeros’ OMS721 for IgA nephropathy Phase III trial has good chance to reach efficacy with longer trial duration while overcoming placebo-effect woes, experts say	02 Nov 2018	Krystnell Storr
Omeros’ OMS721 likely to have tough road for FDA filing, approval in hematopoietic stem cell transplant-associated thrombotic microangiopathies due to minimal data and trial design, experts say	12 Sep 2018	Arafa Salam
Omeros needs to consider USD 10-50 price tag for OMS302 in retinal surgery to corner large market share - ophthalmologists	18 Dec 2013	Casey McDonald

Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.

Drug Insights:

Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
Material intelligence on competitors, including breaking news
Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships

Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Gain a 360-degree view of Omeros Corp and make more informed decisions for your business

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer